
Intellia Therapeutics Inc
NTLANASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$13.70
Day High
$14.30
Day Low
$13.12
Prev. Close
$13.68
VolumeShares traded today.
5.10M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$1.97B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-3.98
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$28.25
52W LowLowest price over the past 52 weeks.
$6.92
50D MAAverage closing price over the last 50 trading days.
$13.57
200D MAAverage closing price over the last 200 trading days.
$13.28
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+13.7%1M
+13.1%6M
+64.6%YTD
+52.8%1Y
+96.5%About
Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia's ex vivo programs use CRISPR to create the therapy by using engineered human cells to treat cancer and autoimmune diseases.
www.intelliatx.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade NTLA
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.